EPISODE · May 6, 2025 · 22 MIN
Updates in Chronic Kidney Disease Management - Ep 160
from ACCP JOURNALS · host ACCP JOURNALS
The authors evaluate the efficacy and safety of emerging therapeutic strategies for CKD management, including sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), finerenone, sacubitril/valsartan, and potassium binders. Read the full text manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70014.
What this episode covers
The authors evaluate the efficacy and safety of emerging therapeutic strategies for CKD management, including sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), finerenone, sacubitril/valsartan, and potassium binders. Read the full text manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70014.
NOW PLAYING
Updates in Chronic Kidney Disease Management - Ep 160
No transcript for this episode yet
Similar Episodes
Jun 16, 2026 ·21m
Jun 15, 2026 ·18m
Jun 15, 2026 ·38m
Jun 14, 2026 ·28m
Jun 13, 2026 ·29m
Jun 12, 2026 ·11m